Pancreatic Cancer Research

ResearcherWenzhou Medical UniversityActive in the last 2 years

Zhaohong Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9958-4944; OpenAlex author ID A5101815833. Sources: OpenAlex.

Their work

Papers
15 (first author 2, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
21
Papers, trials and grants by year

2011: 1 paper · 2012: 3 papers · 2013: 3 papers · 2014: 1 paper · 2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: 2 papers · 2021: none · 2022: none · 2023: none · 2024: 2 papers · 2025: 1 paper

Papers 15

  1. Rg3 inhibits hypoxia-induced tumor exosomes from boosting pancreatic cancer vasculogenic mimicry through the HIF-1α/LARS1/mTOR axis. Co-author DOI 10.1016/j.phymed.2025.156437↗
  2. Ginsenoside Rg3 suppresses vasculogenic mimicry by impairing DVL3-maintained stemness via PAAD cell-derived exosomal miR-204 in pancreatic adenocarcinoma. First author DOI 10.1016/j.phymed.2024.155402↗
  3. Andrographolide induces protective autophagy and targeting DJ-1 triggers reactive oxygen species-induced cell death in pancreatic cancer. Co-author DOI 10.7717/peerj.17619↗
  4. Emodin Reverses Gemcitabine Resistance of Pancreatic Cancer Cell Lines Through Inhibition of IKKβ/NF-κB Signaling Pathway. Last author DOI 10.2147/ott.s253691↗
  5. Effects of evodiamine on PI3K/Akt and MAPK/ERK signaling pathways in pancreatic cancer cells. First author DOI 10.3892/ijo.2020.4956↗
  6. Emodin sensitizes human pancreatic cancer cells to EGFR inhibitor through suppressing Stat3 signaling pathway. Co-author DOI 10.2147/cmar.s221877↗
  7. Emodin inhibits angiogenesis in pancreatic cancer by regulating the transforming growth factor-β/drosophila mothers against decapentaplegic pathway and angioge… Co-author DOI 10.3892/mmr.2015.4158↗
  8. Ginsenoside Rg3 inhibition of vasculogenic mimicry in pancreatic cancer through downregulation of VE‑cadherin/EphA2/MMP9/MMP2 expression. Co-author DOI 10.3892/ijo.2014.2500↗
  9. Involvement of endoplasmic reticulum stress in capsaicin-induced apoptosis of human pancreatic cancer cells. Co-author DOI 10.1155/2013/629750↗
  10. Involvement of the phosphoinositide 3-kinase/Akt pathway in apoptosis induced by capsaicin in the human pancreatic cancer cell line PANC-1. Co-author DOI 10.3892/ol.2012.991↗
  11. Antiangiogenic effects of oxymatrine on pancreatic cancer by inhibition of the NF-κB-mediated VEGF signaling pathway. Co-author DOI 10.3892/or.2013.2529↗
  12. Antitumor activity of emodin against pancreatic cancer depends on its dual role: promotion of apoptosis and suppression of angiogenesis. Co-author DOI 10.1371/journal.pone.0042146↗
  13. Oridonin enhances antitumor activity of gemcitabine in pancreatic cancer through MAPK-p38 signaling pathway. Co-author DOI 10.3892/ijo.2012.1519↗
  14. Enhanced antitumor efficacy of gemcitabine by evodiamine on pancreatic cancer via regulating PI3K/Akt pathway. Co-author DOI 10.7150/ijbs.8.1↗
  15. [Role of nuclear factor-kappaB on emodin-induced sensitization of pancreatic cancer to gemcitabine]. Co-author PMID 21542284↗

Closest collaborators

The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Heqi Bu · 7 shared papers, 2012–2025 · strength 1.00
  2. Xufan Cai · 3 shared papers, 2024–2025 · strength 0.86
  3. Shengzhang Lin · 5 shared papers, 2012–2025 · strength 0.69
  4. Hongfei Tong · 9 shared papers, 2012–2020 · strength 0.57
  5. Sheng‐Zhang Lin · 5 shared papers, 2012–2024 · strength 0.42
  6. Tingting Zhao · 1 shared paper, 2025 · strength 0.30
  7. Zhong Hong · 2 shared papers, 2019–2020 · strength 0.22
  8. Hui Chen · 1 shared paper, 2020 · strength 0.11
  9. Muhammad Babar Jamshed · 1 shared paper, 2020 · strength 0.11
  10. Qiyu Zhang · 1 shared paper, 2020 · strength 0.11
  11. Qiyu Zhang · 1 shared paper, 2019 · strength 0.11
  12. Jian-Hong Zhang · 3 shared papers, 2012–2013 · strength 0.10
  13. Hongchun Guo · 3 shared papers, 2012 · strength 0.09
  14. Jing-Qiang Guo · 2 shared papers, 2014–2015 · strength 0.09
  15. Hui Chen · 2 shared papers, 2013–2014 · strength 0.08
  16. Shengzhang Lin · 2 shared papers, 2011–2013 · strength 0.07
  17. Dian-Lei Liu · 2 shared papers, 2012 · strength 0.06
  18. Weitian Wei · 2 shared papers, 2012 · strength 0.06
  19. Liang Chen · 1 shared paper, 2014 · strength 0.04
  20. Jianhong Zhang · 1 shared paper, 2013 · strength 0.03
  21. An Liu · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.